Devonian Health Group Inc (GSD : TSX-V)
Common Stock
$9.00
CAD
+1.99 (28.39%)
Last updated: 2026-07-20
GSD
Devonian Health Group Inc
WealthAwesomePerformance
1 Day
+28.39%
1 Week
+28.57%
1 Month
-14.29%
YTD
-21.05%
Key Statistics
Market Cap
$19.47M
52W High
$15.00
52W Low
$0.19
P/E Ratio
-
50 Day MA
$9.96
200 Day MA
$11.22
Beta
1.26
Dividend Yield
-
Technical Indicators
Price vs 50-Day SMA
Price vs 200-Day SMA
Recent Price History
| Date | Open | High | Low | Close | Adj Close | Volume |
|---|---|---|---|---|---|---|
| 7/20/2026 | $7.00 | $9.00 | $7.00 | $9.00 | $9.00 | 2,120 |
| 7/17/2026 | $7.10 | $7.10 | $7.01 | $7.01 | $7.01 | 321 |
| 7/15/2026 | $10.06 | $10.06 | $10.06 | $10.06 | $10.06 | 1,003 |
| 7/14/2026 | $10.14 | $10.14 | $10.14 | $10.14 | $10.14 | 290 |
| 7/13/2026 | $7.26 | $7.26 | $7.00 | $7.00 | $7.00 | 1,806 |
| 7/10/2026 | $8.75 | $8.75 | $8.00 | $8.00 | $8.00 | 380 |
| 7/9/2026 | $9.00 | $9.00 | $9.00 | $9.00 | $9.00 | 110 |
| 7/8/2026 | $5.12 | $5.12 | $5.12 | $5.12 | $5.12 | 129 |
| 7/7/2026 | $5.10 | $5.10 | $5.10 | $5.10 | $5.10 | 316 |
| 7/6/2026 | $7.50 | $7.50 | $7.17 | $7.17 | $7.17 | 1,400 |
Wealth Awesome Price Forecast
WA ModelStatistical 90-day price range based on GSD's historical volatility
30-Day Vol
285.7%
Annualized
90-Day Vol
195.8%
Annualized
Trend (90d)
-50.0%
Annualized drift
90d Mean
C$7.53
Expected price
| Horizon | Expected | 68% Range (1σ) |
|---|---|---|
| 30 trading days | C$8.48 | C$3.16 – C$22.73 |
| 60 trading days | C$7.99 | C$1.98 – C$32.21 |
| 90 trading days | C$7.53 | C$1.37 – C$41.52 |
Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ±1σ, 95% band = ±2σ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.
About Devonian Health Group Inc
Devonian Health Group Inc. engages in the development of botanical drugs. Its lead product candidate is Thykamine that is in phase 3 clinical trial for the treatment of Atopic dermatitis in adult population; in phase 2/3 clinical trial for Atopic dermatitis in pediatric population; in phase 2 clinical trial for HFS associated to chemotherapy; and in phase 2/3 clinical trial for Radiodermatitis associated to radiotherapy, as well as in phase 2a clinical trial for ulcerative colitis. The company also develops Pantoprazole Magnesium for the treatment of gastric reflux; Cleo-35 for the treatment of hormonal acne in women; R-Spinasome anti-aging cream, serum, and regenerating creams; and anti-aging products, including day, night, and eye creams under the Purgenesis name. Devonian Health Group Inc. is headquartered in Québec, Canada.
Financials
- Revenue (TTM)
- $3.00M
- EBITDA
- $-5.92M
- Profit Margin
- -204.08%
- ROE (TTM)
- -77.33%
- EPS (Diluted)
- -2.25
- Book Value
- 2.51
Classification
- Sector
- Health Care
- Industry
- Biotechnology
- Group
- Pharmaceuticals, Biotechnology & Life Sciences
🔄 Recent Splits
1-for-60
Jan 22, 2026
Advertisement
7 stocks to buy and hold forever
Blue-chip dividend stocks for long-term wealth building.
Get the FREE ReportExplore More
Common Questions About GSD
Articles Featuring GSD.V
Latest articles and analysis covering GSD.V
Why Devonian Health Group Inc stock is skyrocketing yesterday
Devonian Health Group Inc. saw a striking increase in its stock price yesterday, closing at CA$9.00. This 28.39% rise comes amid ongoing financial challenges, making it a noteworthy event for investors.
Why Devonian Health Group Inc stock is skyrocketing today
Devonian Health Group Inc (GSD.V) has experienced a remarkable 14.12% increase in its stock price today, closing at CA$8.00. This surge comes amid ongoing efforts by the company to consolidate shares and prepare for a potential listing on a U.S. exchange, which could significantly enhance its market presence.
Why Devonian Health Group Inc stock is skyrocketing today
Devonian Health Group Inc's stock has skyrocketed by 44.86% in one trading day, closing at CA$10.14. This surge is attributed to investor optimism about the company's strategic initiatives, including a share consolidation for a potential U.S. listing.
Why Devonian Health Group Inc stock is plummeting today
Devonian Health Group Inc's stock has taken a significant hit today, dropping 12.50% as investors react to the company's financial struggles and strategic decisions. With a market cap of CA$22.2 million, the future looks uncertain for this small-cap player.
Why Devonian Health Group Inc stock is plummeting today
Devonian Health Group Inc's stock plummeted by 11.11% today, closing at CA$8.00, amid concerns over its financial performance and cash reserves. Investors are wary as the company reported significant net losses in recent quarters, raising questions about its future viability.
Why Devonian Health Group Inc stock is plummeting today
Devonian Health Group Inc. has seen its stock price drop by 11.11% in the latest trading session, closing at CA$8.00. This decline raises concerns about the company's financial health as it continues to report significant losses without any recent positive developments.
Why Devonian Health Group Inc stock is plummeting today
Devonian Health Group Inc's stock plummeted nearly 29% yesterday, raising alarms about its financial stability and future growth potential. Investors are left questioning the company's direction amidst ongoing losses.
Why Devonian Health Group Inc stock is plummeting today
Devonian Health Group Inc (GSD.V) has seen a sharp decline in its stock price, dropping 6.37% in the last trading session. With a market cap of CA$20.8 million and a troubling financial outlook, investors are left questioning the company's future.
Why Devonian Health Group Inc stock is plummeting today
Devonian Health Group Inc's stock has taken a hit, dropping over 6% in the latest session. With ongoing financial losses and no recent positive developments, investors are left questioning the company's future.
Why Devonian Health Group Inc stock is plummeting today
Devonian Health Group Inc's stock has plummeted by 12% today, raising alarms about its financial performance and future viability. Investors are left questioning the sustainability of the company's operations amidst ongoing losses.
Why Devonian Health Group Inc stock is plummeting today
Devonian Health Group Inc's stock plummeted by over 5% today, driven by concerns over its financial performance and ongoing operational challenges.
